Company Overview and News

4
Perseus Mining Limited: Activity Report for March 2018 Quarter

2018-04-15 globenewswire
PERTH, Australia, April 15, 2018 (GLOBE NEWSWIRE) -- Perseus Mining Limited (“Perseus” or the “Company”) (TSX:PRU) (ASX:PRU) reports on its activities for the three month period ended March 31, 2018 (the “Quarter”). An executive summary is provided below. However, full details of activities in the March Quarter, including reconciled production and all-in site cash costs, are included in the Company’s March 2018 Quarterly Activity Report released to the market on April 16, 2018.
AMA PMNXF MALRY PRU MALRF CLUGF PRU MIN

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to LSE:AMA / AMARA MINING PLC on message board site Silicon Investor.

Canu0027t Beat Amazon! Canu0027t Beat Amazon! Canu0027t Beat Amazon! Amazon.com, Inc. (AMZN) Amazon.com, Inc. (AMZN) Amazon.com, Inc. (AMZN)
Applied Materials No-Politics Thread (AMAT) Applied Materials No-Politics Thread (AMAT) Applied Materials No-Politics Thread (AMAT) Amaya Gaming Group Inc. Amaya Gaming Group Inc. Amaya Gaming Group Inc.
President Barack Obama President Barack Obama President Barack Obama The Obama - Clinton Disaster The Obama - Clinton Disaster The Obama - Clinton Disaster
Obama Joke Thread Obama Joke Thread Obama Joke Thread Amazon short Amazon short Amazon short
Amazon vs. Alibaba Amazon vs. Alibaba Amazon vs. Alibaba Fast and Furious-----Obama/Holder Gun Running Scandal Fast and Furious-----Obama/Holder Gun Running Scandal Fast and Furious-----Obama/Holder Gun Running Scandal